Value in Prescribing biological disease-modifying antirheumatic drugs (bDMARDS) Program


Targeted Therapies Alliance

The Society of Hospital Pharmacists of Australia (SHPA) has joined NPS MedicineWise and seven other organisations representing pharmacists, specialists, consumers and research experts to form the Targeted Therapies Alliance (the Alliance). The Alliance provides stewardship and direction about the safe and wise use of biological disease-modifying antirheumatic drugs (bDMARDs) and other specialised medicines.


Rheumatology interventions

The Alliance has developed information and resources for health professionals and consumers, including practical tools for people with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS).

Resources for pharmacists

For more information, visit the Rheumatology conditions for health professionals page on the NPS MedicineWise website.

Patient resources

  • Video: Living with methotrexate
    In this video, consumer Suzanne talks about her treatment journey and the impact methotrexate has had on her rheumatoid arthritis.
  • Methotrexate action plan (PDF)
    This action plan can help patients discuss methotrexate with their rheumatologist and plan the best way to take their medicine.

For more information, visit the Rheumatology conditions for consumers page on the NPS MedicineWise website.


Dermatology and gastroenterology interventions

The Alliance is currently working closely with dermatology and gastroenterology professional and consumer organisations to design and develop resources and materials for these conditions, and these will be available from mid-2021.